About Charles River Laboratories
Charles River Laboratories is a company based in Wilmington (United States) founded in 1947. The company has 20,100 employees as of December 31, 2024. Charles River Laboratories has completed 29 acquisitions, including Accugenix, Agilux Laboratories and Argenta Discovery. Charles River Laboratories offers products and services including Research Models, Integrated Drug Discovery, Antibody Discovery Services, and Biologics Testing. Charles River Laboratories operates in a competitive market with competitors including Cytel, LabCorp, Precision Medicine Group, Frontage Laboratories and Precision for Medicine, among others.
- Headquarter Wilmington, United States
- Employees 20100 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Charles River Laboratories International, Inc.
-
Annual Revenue
$4.05 B (USD)-1.92as on Dec 31, 2024
-
Net Profit
$10.3 M (USD)-97.83as on Dec 31, 2024
-
EBITDA
$928.62 M (USD)-4.78as on Dec 31, 2024
-
Latest Funding Round
$1.3 M (USD), Grant
Jun 11, 2024
-
Investors
NIH
& 4 more
-
Employee Count
20100
as on Dec 31, 2024
-
Investments & Acquisitions
Accugenix
& 28 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Charles River Laboratories
Charles River Laboratories is a publicly listed company on the NYSE with ticker symbol CRL in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Charles River Laboratories
Charles River Laboratories offers a comprehensive portfolio of products and services, including Research Models, Integrated Drug Discovery, Antibody Discovery Services, and Biologics Testing.
Supplies animal models for basic research and testing purposes.
Accelerates discovery through comprehensive target and lead optimization services.
Offers tailored solutions for antibody therapeutic development and IND support.
Provides testing for biologics from discovery to commercialization stages.
People of Charles River Laboratories
Unlock access to complete
Software Development Team
73 people
Leadership Team
64 people
Sales and Marketing
56 people
Human Resources and Administration
42 people
Senior Team
23 people
Product Management Team
22 people
Operations Team
21 people
Data Analysis and Operations Team
12 people
Unlock access to complete
Funding Insights of Charles River Laboratories
Investors in Charles River Laboratories
Charles River Laboratories has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Charles River Laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Charles River Laboratories
Charles River Laboratories has strategically engaged in corporate development activities, having acquired 29 companies. Notable acquisitions include Accugenix, Agilux Laboratories and Argenta Discovery.
Investment portfolio details for Charles River Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Detection, quality control, and veterinary services are provided worldwide.
|
Locked | Locked | 2015 | Locked | |
|
Research reagents for drug discovery and functional genomics are developed.
|
Locked | Locked | 2012 | Locked | |
|
Provider of in vitro and in vivo testing services
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for Charles River Laboratories
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Charles River Laboratories
Detailed financials for Charles River Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Charles River Laboratories Comparisons
Peer comparison for Charles River Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Charles River Laboratories
Charles River Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytel, LabCorp, Precision Medicine Group, Frontage Laboratories and Precision for Medicine, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Provider of laboratory tests for physicians
|
|
| Locked | Locked | Locked |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| Locked | Locked | Locked |
Early drug development services are provided for pharma firms.
|
|
| Locked | Locked | Locked |
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
|
Detailed competitors of Charles River Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Charles River Laboratories
Complete news archive for Charles River Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Charles River Laboratories
Charles River Laboratories was founded in 1947 and raised its 1st funding round 57 years after it was founded.
Charles River Laboratories is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
As of Dec 31, 2024, the latest employee count at Charles River Laboratories is 20,100.
Annual revenue of Charles River Laboratories is $4.05B as on Dec 31, 2024.
Charles River Labs offers drug discovery and preclinical development services to pharma and biotech companies. Their services span the entire drug discovery pathway namely target discovery and validation, hit finding, medicinal chemistry, in vivo and in-vitro pharmacology, biomarker development, and IND-enabling studies for both small molecules and biologics. They cater to therapeutic areas such as Oncology, CNSpain, Inflammation, Immunology, Cardiovascular, Metabolic, Respiratory, Rare and neglected diseases, and others. In 2020, the company recorded annual revenues of 2.9 B and a net profit of 364.3 M.
Charles River Laboratories's top competitors include LabCorp, Cytel and Precision Medicine Group.
Charles River Laboratories offers Research Models, Integrated Drug Discovery, Antibody Discovery Services, and Biologics Testing.
Yes, Charles River Laboratories is publicly traded on NYSE under the ticker symbol CRL.
Charles River Laboratories has made 29 acquisitions, including Accugenix, Agilux Laboratories, and Argenta Discovery.
Charles River Laboratories has 5 investors. Key investors include NIH, HHS, European Union, Foundation for Chemistry Research & Initiatives, and OSTI.GOV.
The ticker symbol of Charles River Laboratories is CRL on NYSE.